SCHEMBL15434693

SCHEMBL15434693

CN1CCN(CCC(C)(C)C(=O)Cl)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.42
TP53 P04637 2/20 0.40
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
HDAC6 Q9UBN7 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
CNR1 P21554 1/20 0.35
CYP1A2 P05177 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327831 0.82 PAOX (0.43) PAOXTP53KDM4EALDH1A1SIGMAR1
SCHEMBL8842340 0.82 PAOX (0.43) PAOXTP53KDM4EALDH1A1HDAC6
SCHEMBL15434606 0.81 SMN1; SMN2 (0.54) KDM4EALDH1A1SMN1; SMN2
SCHEMBL19407922 0.78 L3MBTL1 (0.40) PAOXTP53KDM4EALDH1A1HDAC6
SCHEMBL15434627 0.75 CYP4F2 (0.47) PAOXKDM4EALDH1A1SIGMAR1TDP1
SCHEMBL24769802 0.74 ALDH1A1 (0.40) PAOXTP53ALDH1A1SIGMAR1CHRM2
SCHEMBL18736050 0.74 ALDH1A1 (0.40) PAOXTP53ALDH1A1TSHRMAPT
SCHEMBL16940032 0.74 ALDH1A1 (0.40) PAOXTP53ALDH1A1SIGMAR1SMN1; SMN2
SCHEMBL16940036 0.73 ALDH1A1 (0.45) PAOXTP53KDM4EALDH1A1
SCHEMBL15434662 0.73 ALDH1A1 (0.45) PAOXTP53KDM4EALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240229026-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2024-07-11 US disclosed
US-20240229026-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2024-07-11 US disclosed
EP-4219516-A2 CHIRAL CONTROL Wave Life Sciences Ltd. (SG) 2023-08-02 EP disclosed
US-11643657-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2023-05-09 US disclosed
US-11643657-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2023-05-09 US disclosed
EP-2872147-B1 METHOD FOR MAKING CHIRAL OLIGONUCLEOTIDES WAVE LIFE SCIENCES LTD (SG) 2022-12-21 EP disclosed
US-20210130821-A1 CHIRAL CONTROL WAVE LIFE SCIENCES LTD. (SG) 2021-05-06 US disclosed
US-10590413-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2020-03-17 US disclosed
US-9982257-B2 Chiral control WAVE LIFE SCIENCES LTD. (SG) 2018-05-29 US disclosed
US-9885037-B2 2018-02-06 US disclosed
US-20170275621-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2017-09-28 US disclosed
US-20170275621-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2017-09-28 US disclosed
US-20150211006-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2015-07-30 US disclosed
US-20150211006-A1 CHIRAL CONTROL WAVE LIFE SCIENCES USA, INC. 2015-07-30 US disclosed
WO-2014012081-A2 CHIRAL CONTROL ONTORII, INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130821-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885
US-20170275621-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885
US-20240229026-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885
US-20150211006-A1 CHIRAL CONTROL RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885
US-11643657-B2 Chiral control RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885
US-10590413-B2 Chiral control RNGTT, POLI, NSUN3 PAOX 3863/4885TP53 1404/4885KDM4E 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.